Effects of eight antibacterial agents on cell survival and expression of epithelial-cell-or cell-adhesion-related genes in human gingival epithelial cells

Journal of Periodontal Research

Volumn 39, Issue 1, 2004, Pages 50-58

  Inoue, Kiichiro ^a   Kumakura, Shin Ichi ^a   Uchida, Minoru ^a   Tsutsui, Takeki ^a,b  

^a NIPPON DENTAL UNIVERSITY   (Japan)

^b The Nippon Dental University   (Japan)

Author keywords

Antibacterial agents; Cellular survival; Gene expression; Human gingival epithelial cells

Indexed keywords

ANTIINFECTIVE AGENT; AZITHROMYCIN; BETA1 INTEGRIN; BETA4 INTEGRIN; CLARITHROMYCIN; ENOXACIN; ERYTHROMYCIN; ISOPROTEIN; KALININ; KERATIN; KERATINOCYTE GROWTH FACTOR RECEPTOR; MESSENGER RNA; MINOCYCLINE; OFLOXACIN; PROTEIN SUBUNIT; ROXYTHROMYCIN; TETRACYCLINE; UNCLASSIFIED DRUG; FIBROBLAST GROWTH FACTOR; INTEGRIN; LAMININ; PROTEIN; ROXITHROMYCIN;

ARTICLE; BACTERIUM; CELL ADHESION; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; EPITHELIUM CELL; GENE EXPRESSION; GENETIC ASSOCIATION; GINGIVA; HUMAN; HUMAN CELL; LD 50; MINIMUM INHIBITORY CONCENTRATION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REGENERATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; CELL DIVISION; CYTOLOGY; GENETICS;

ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CELL ADHESION; CELL DIFFERENTIATION; CELL DIVISION; CELL LINE; CELL SURVIVAL; CLARITHROMYCIN; ENOXACIN; EPITHELIAL CELLS; ERYTHROMYCIN; FIBROBLAST GROWTH FACTORS; GINGIVA; HUMANS; INTEGRINS; KERATINS; LAMININ; LETHAL DOSE 50; MINOCYCLINE; OFLOXACIN; PROTEINS; ROXITHROMYCIN; TETRACYCLINE;

EID: 1542758222     PISSN: 00223484     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2004.00704.x     Document Type: Article

References (37)

1. Ishikawa I, Umeda M, Laosrisin N. Clinical, bacteriological, and immunological examinations and the treatment process of two Papillon-Lefevre syndrome patients. J Periodontol 1994;65:364-371.
2. Barone A, Sbordone L, Ramaglia L, Ciaglia RN. Microbiotical associated with refractory periodontitis. Prevalence and antibiotic susceptibility. Minerva Stomatol 1999;48:191-201.
3. Miyake Y, Tsuruda K, Okuda K, Widowati, Iwamoto Y, Suginaka H. In vitro activity of tetracyclines, macrolides, quinolones, clindamycin and metronidazole against periodontopathic bacteria. J Periodont Res 1995;30:290-293.
4. Goldstein EJC, Citron DM, Merrian CV, Warren Y, Tyrrell K. Activities of telithromycin (HMR 3647, RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and other antimicrobial agents against unusual anaerobes. Antimicrob Agents Chemother 1999;43:2801-2805.
5. Omori N, Kobayashi H, Tsutsui T. Quantitative comparison of cytocidal effects of tetracyclines and fluoroquinolones on human periodontal ligament fibroblasts. J Periodont Res 1999;34:290-295.
6. Someya T, Tamura Y, Tsutsui T. Cytological and cytogenetic effects of the fluoroquinolones ofloxacin on human periodontal ligament fibroblasts. J Periodont Res 2000;35:352-360.
7. Maizumi N, Tamura Y, Kanai H, Tsutsui T. Quantitative comparison of the cytocidal effect of seven macrolide antibiotics on human periodontal ligament fibroblasts. J Periodont Res 2002; 37:250-254.
8. Das SJ, Olsen I. Up-regulation of keratinocyte growth factor and receptor: a possible mechanism of action of phenytoin in wound healing. Biochem Biophys Res Commun 2001;282:875-881.
9. Dabelsteen S, Wandall HH, Gron B, Dabelsteen E. Keratinocyte growth factor mRNA expression in periodontal ligament fibroblasts. Eur J Oral Sci 1997;105:593-598.
10. Hansson A, Bloor BK, Haig Y, Morgan PR, Ekstrand J, Grasfström RC. Expression of keratins in normal, immortalized and malignant oral epithelia in organotypic culture. Oral Oncol 2001;37:419-430.
11. Gräber H-G, Conrads G, Wilharm J, Lampert F. Role of interactions between integrins and extracellular matrix components in healthy epithelial tissue and establishment of a long junctional epithelium during periodontal wound healing: a review. J Periodontol 1999;70:1511-1522.
12. Gürses N, Thorup AK, Reibel J, Carter GW, Holmstrup P. Expression of VLA-integrins and their related basement membrane ligands in gingiva from patients of various periodontitis categories. J Clin Periodontol 1999;26:217-224.
13. Hormia M, Sahlberg C, Thesleff I, Airenne T. The epithelium-tooth interface - a basal lamina rich in laminin-5 and lacking other known laminin isoforms. J Dent Res 1998;77:1479-1485.
14. Burgeson RE, Chiquet M, Deutzmann R et al. A new nomenclature for the laminins. Matrix Biol 1994;14:209-211.
15. Igarashi F, Uchida M, Tsutsui T. Establishment and characterization of cultured human gingival keratinocytes immortalized by transfection of origin (-) SV40 DNA and c-fos gene (in Japanese). Odontology 1998;86:37-47.
16. Witte I, Oetken G, Buschfort C, Hartmann A. A comparison of the DNA-damaging the cytotoxic and genotoxic properties of tetracycline in human fibroblasts in the presence and absence of light. Mutat Res 1994;315:33-40.
17. Umezawa N, Arakane N, Ryu A, Mashito S, Hirobe M, Nagano T. Participation of reactive oxygen species in phototoxicity induced by quinolone antibacterial agents. Arch Biochem Biophys 1997;342:275-281.
18. Kumakura S, Yamamoto A, Yagisawa J, Uchida M, Tsutsui T. Telomere length and telomerase activity in the process of human fibroblast immortalization. Odontology 2002;90:13-21.
19. Dimmler A, Gerhards R, Betz C et al. Transcription of cytokeratins 8, 18, and 19 in bone marrow and limited expression of cytokeratins 7 and 20 by carcinoma cells: inherent limitations for RT-PCR in the detection of isolated tumor cells. Lab Invest 2001;81:1351-1361.
20. Bouchet BY, Colon M, Polotsky A, Shikani AH, Hungerford DS, Frondoza CG. Beta-1 integrin expression by human nasal chondrocytes in microcarrier spinner culture. J Biomed Mater Res 2000;52:716-724.
21. 4A integrin subunit in relation to the differentiation state in human intestinal cells. J Biol Client 1999;274:29819-29825.
22. Manda R, Kohno T, Niki T et al. Differential expression of the LAMB 3 and LAMC 2 genes between small cell and non-small cell lung carcinomas. Biochem Biophys Res Commun 2000;275:440-445.
23. Horikawa I, Oshimura M, Barrett JC. Repression of the telomerase catalytic subunit by a gene on human chromosome 3 that induces cellular senescence. Mol Carcinog 1998;22:65-72.
24. INK4a and pRb inactivation with immortalization of human cells. Carcinogenesis 2002;23:2111-2117.
25. Sato H, Tsutsui T. Effect of tetracyclines on cell survival of cultured human gingival keratinocytes and intracellular concentrations of incorporated tetracyclines (in Japanese). J Japan Soc Periodont 1998; 40:1-8.
26. Chambers HF. Antimicrobial agents, protein synthesis inhibitors and miscellaneous antibacterial agents. In: Hardman, JG, Limbird LE, Gilman AG, eds. Goodman and Gilman's the pharmacological basis of therapeutics. New York: Macmillan, 2001: 1239-1256.
27. Kojima K, Tanaka Y, Matsudo Y, Tsutsui T. Influence of tetracyclines and pyridonecarboxylic acids on cultured human gingival keratinocytes (in Japanese). J Japan Soc Periodont 1996;38:465-476.
28. Japan Pharmaceutical Information Center. Drugs in Japan, ethical drugs (in Japanese). Tokyo, Japan: Yakugyo Jiho Co. Ltd, 1998 99.
29. Piccolomini R, Catamo G, DiBonaventura G. Bacteriostatic and bactericidal in vitro activities of clarithromycin and erythromycin against periodntopathic Actinobacillus actinomycetemcomitans. Antimicrob Agents Chemother 1998;42: 3000-3001.
30. Piccolomini R, DiBonaventura G, Catamo G, Picciani C, Paolantonio M. In vitro antimicrobial susceptibility of periodontopathic Actinobacillus actinomycetemcomitans to roxithromycin and erythromycin. Oral Microbiol Immunol 1997;12:366-371.
31. Pajukanta R, Asikainen S, Saarela M, Alaluusua S, Jousimies-Somer H. In vitro activity of azithromycin compared with that of erythromycin against Actinobacillus actinomycetemcomitans. Antimicrob Agents Chemother 1992;36:1241-1243.
32. Shen LL, Pernet AG. Mechanism of inhibition of DNA gyrase by analogues of nalidixic acid: the target of the drug is DNA. Proc Natl Acad Sci USA 1985;82: 307-311.
33. Hussy P, Maass G, Tummler B, Grosse F, Schomburg U. Effect of 4-quinolones and novobiocin on calf thymus DNA polymerase α primase complex, topoisomerases I and II, and growth of mammalian lymphoblasts. Antimicrob Agents Chemother 1986;29:1073-1078.
34. Miller KG, Liu LF, Englund PT. A homogeneous type II DNA topoisomerase from the HeLa cell nuclei. J Biol Chem 1981;256:9334-9339.
35. Rusquet R, Bonhommet M, David JC. Quinolone antibiotics inhibit eucaryotic DNA polymerase α and β terminal deoxynucleotidyl transferase but not DNA ligase. Biochem Biophys Res Commun 1984;121:762-769.
36. Christ W, Lehnert T, Ulbrich B. Specific toxicologic aspects of the quinolones. Rev Infect Dis 1988;10:S141-S146.
37. Halkin H. Adverse effects of the fluoroquinolones. Rev Infect Dis 1988;10:S258-S261.